Key statistics
Valuation, profitability, and growth metrics
- Market cap
- 153.69M USD
- Enterprise value
- 79.55M USD
- Trailing P/E
- —
- Forward P/E
- -1.75
- Price / sales
- 115.12
- Price / book
- 1.40
- EV / EBITDA
- -1.05
- Beta
- 2.79
- Dividend yield
- —
- Profit margin
- 0.00%
- Return on equity
- -121.86%
- Debt / equity
- 5.69
- Earnings growth
- —
- Revenue growth
- —
- Free cash flow
- -32.6M USD
- Operating cash flow
- -52.33M USD
- Shares outstanding
- 224.23M
- Sector
- Healthcare
- Industry
- Biotechnology
Updated Sep 2, 2026, 4:11 AM